Y-mAbs Therapeutics Inc (YMAB)
13.62
-3.62
(-20.97%)
USD |
NASDAQ |
May 08, 15:59
Y-mAbs Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
Date | Value |
---|---|
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
--
Maximum
Dec 2020
--
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
The Cooper Companies Inc | 0.3597 |
Puma Biotechnology Inc | 1.962 |
Humacyte Inc | -- |
Moderna Inc | 0.00 |
NovaBay Pharmaceuticals Inc | 0.3431 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 127.87M |
Total Liabilities (Quarterly) | 26.88M |
Shareholders Equity (Quarterly) | 100.98M |
Current Ratio | 5.520 |